References
Feuerstein G (1985) The opioid system and central cardiovascular control: analysis of controversies. Peptides 6: 51–56
Holaday JW (1983) Cardiovascular effects of endogenous opiate systems. Annu Rev Pharmacol Toxicol 23: 541–594
Montastruc JL, Richard JP, Cathala B (1985) Naloxone fails to reverse blood pressure in shock: a double blind study in man. J Pharmacol 16: 313–314
Tiengo M (1980) Naloxone in irreversible shock. Lancet 1: 690
Bertolini A, Poggioli R, Vergoni AV, Castelli M, Guarini S (1986) Evidence that melanocortins are physiological antagonists of opioids. In: de Wied D, Ferrari W (eds) Central actions of ACTH and related peptides. Springer-Verlag, Berlin Heidelberg, p 207–222
Bertolini A, Guarini S, Ferrari W (1986) Adrenal-independent, anti-shock effect of ACTH-(1–24) in rats. Eur J Pharmacol 122: 387–388
Bertolini A, Guarini S, Ferrari W, Rompianesi E (1986) Adrenocorticotropin reversal of experimental hemorrhagic shock is antagonized by morphine. Life Sci 39: 1271–1280
Bertolini A, Guarini S, Rompianesi E, Ferrari W (1986) α-MSH and other ACTH fragments improve cardiovascular function and survival in experimental hemorrhagic shock. Eur J Pharmacol 130: 19–26
Mandel W, Singer MJ, Gudmunson HR, Meister L, Modern FWS (1951) Intravenous use of pituitary adrenocorticotropic hormone (ACTH). A report on its administration in twenty-five patients. JAMA 146: 546–551
Schadt JC, Gaddis RR (1985) Endogenous opiate peptides may limit norepinephrine release during hemorrhage. J Pharmacol Exp Ther 232: 656–660
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bertolini, A., Guarini, S., Ferrari, W. et al. ACTH-(1–24) restores blood pressure in acute hypovolaemia and haemorrhagic shock in humans. Eur J Clin Pharmacol 32, 537–538 (1987). https://doi.org/10.1007/BF00637684
Issue Date:
DOI: https://doi.org/10.1007/BF00637684